Health

VN successfully produces inactivated seasonal influenza vaccine

he Institute of Vaccines and Medical Biologicals (IVAC) of Vietnam has announced the successful production of inactivated seasonal influenza vaccine (IVACFLU-S) for commercial use.
VN successfully produces inactivated seasonal influenza vaccine ảnh 1Vietnam has successfully produced an inactivated seasonal influenza vaccine. (Source: nld.com.vn)

Hanoi (VNA) - TheInstitute of Vaccines and Medical Biologicals (IVAC) of Vietnam has announcedthe successful production of inactivated seasonal influenzavaccine (IVACFLU-S) for commercial use.

The results were recorded after a period of study, trial and production fromJanuary 2015 to January 2018, according to IVAC.

The vaccine targets three strains of influenza: A/H1N1, A/H3N2 and B.

The production process was in line with instructions of the World HealthOrganisation (WHO) and was assessed to meet quality standards, IVAC said.

Quality assessment and clinical trial results showed that the vaccine metquality and safety standards and was in line with WHO’s warnings and Vietnam’s regulations.

If IVAC is licensed to produce the vaccine it will be sold between 80,000-120,000VND (3.5-5.3 USD) per dose.

At present, Vietnam imports influenza vaccine at a price of 240,000-300,000VND (10.6-13.3 USD) per dose.

IVAC proposed State management agencies to recognise its production line with acapacity of 1.5 million doses per year.

Influenza is a leading cause of morbidity and mortality worldwide. Seasonalinfluenza causes 250,000-500,000 fatalities and up to five million cases ofsevere illness across the globe every year.

If a highly virulent pandemic strain were to emerge, influenza could causemillions of fatalities around the world.

Vietnam reports more than a million cases of influenza-like illnesses everyyear and has reported isolated cases of avian influenza A/H5N1 in humans, astrain with a particularly high fatality rate.

The strain is being monitored for any evolution or adaptations that could turnit into a form that can spread efficiently among people, which will increasethe likelihood of a pandemic.

IVAC, established in 1978 by the Ministry of Health, plans and carries out theproduction of vaccines and serum for the Expanded Programme on Immunisation in Vietnamand the overall prevention and treatment of diseases. It also conducts researchand applies technological advances in vaccine development and production incooperation with organisations both within and outside the country.-VNA
VNA
#Institute of Vaccines and Medical Biologicals #inactivated seasonal influenza vaccine #World Health Organisation #State management agencies #Vietnam #VietnamPlus #Viet Nam News
Follow VietnamPlus

Related News

Illustrative image. (Source: Internet).

New influenza vaccine factory put into operation

A vaccine factory capable of producing about 1.5 million doses of A/H5N1 influenza vaccine for human use a year became operational on December 12 in the central coastal province of Khanh Hoa.
Workers of the Phu Yen Material and Pharmacy Co in the central province of Phu Yen make medicines (Photo: VNA)

Clinical trial says new vaccine ‘safe'

A phase 1 clinical trial of an inactivated influenza A/H5N1 pandemic vaccine candidate (IVACFLU-H5N1), involving 75 participants in southern Long An province's Ben Luc district, has so far proven to safely induce immune responses at various dosage levels in healthy adults.

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.

PM Pham Minh Chinh (second from right) visits the Karolinska Institutet. (Photo: VNA)

PM seeks stronger medical ties with Sweden’s Karolinska Institutet

The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.

D.F (left), a US patient, at a follow-up examination with Do Lenh Hung, head of the department of urethral reconstructive surgery. (Photo: VNA)

High-quality healthcare services attract more foreign patients to Binh Dan Hospital

Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T

A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

Sharp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.

On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

Vietnam, France collaborate in vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.

Medical facilities have been instructed to prepare necessary infrastructure, medical equipment, and supplies to ensure effective patient admission, isolation, diagnosis, treatment, and infection control. - Illustrative image (Photo: VNA)

Enhanced anti-COVID-19 measures in place amid rising cases

According to the World Health Organisation, more than 25,000 COVID-19 cases have been recorded globally over the past month. Notably, from January 1 to May 10, Thailand reported nearly 54,000 infections and 16 deaths. The rise in cases in Thailand has been linked to the spread of XBB.1.16 subvariant.